United States · Investor

Foresite

Filed with the SEC to raise a fund in Jan 2026, closing $11M. Last cheque observed Dec 2019.

QuietNew fund $11M, Jan 2026VC firm

Series CSeries BDebt

Cheques on record
0%of best year0cheques in 12 months, 12 on record
Since the last cheque2512days00hrs00min00sec
Median round$62MRounds led0 of 12Mostly inUnited States, 92%
Pitch Foresite

Foresite highlights

  1. 01

    12 rounds on record

  2. 02

    Mostly Series C and Series B: 75% of its rounds

What they do

Filed 1 private fund offering with the SEC, the most recent in 2021-12From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first12 appearances

  1. 2019

    3 rounds

  2. Dec
    InscriptaSeries D · US · FinSMEs$125MWith 7 others
  3. Apr
    InscriptaSeries C · US · FinSMEs$20MWith 5 others
  4. Feb
    DNAnexusDebt · US · Businesswire$68MWith 5 others
  5. 2018

    7 rounds

  6. Aug
    Orchard TherapeuticsSeries C · GB · FinSMEs$150MWith 14 others
  7. Jun
    Decibel TherapeuticsSeries C · US · FinSMEs$55MWith 8 others
  8. Jun
    SutroSeries E · US · FinSMEs$85MWith 17 others
  9. Mar
    TempestSeries B · US · Businesswire$70MWith 4 others
  10. Feb
    InscriptaSeries C · US · FinSMEs$56MWith 5 others
  11. Feb
    Generation BioSeries B · US · FinSMEs$100MWith 3 others
  12. Feb
    ORICSeries C · US · FinSMEs$50MWith 8 others
  13. 2017

    2 rounds

  14. Aug
    VentaoRXSeries B · US · FinSMEs$42MWith 2 others
  15. Mar
    Solid BiosciencesSeries C · US · FinSMEs$50MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration1 named

JBJames B. TananbaumManaging Member of the General PartneriFiling they signed

We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

5+funds on filenumbered funds in its name

Who they invest alongside

The investors most often in the same rounds as Foresite. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Foresite put money into.

Quick answers about Foresite

What does Foresite invest in?

Foresite invests most often at Series C and Series B (75% of the rounds on record).

How active is Foresite?

12 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2019.

What has Foresite invested in recently?

Its most recent investments on record: Inscripta (Series D, Dec 2019), DNAnexus (Debt, Feb 2019) and Orchard Therapeutics (Series C, Aug 2018).

How big are Foresite's cheques?

The median round it joins is $62M.

Does Foresite lead rounds?

Rarely, if at all: none of its 12 investments on record names it as the lead.

Where does Foresite invest?

Most of the companies it backs are in the United States (92%) and the United Kingdom (8%).

Is Foresite investing now?

No investments in the last 12 months; the latest was in Dec 2019.

Who does Foresite invest alongside?

Most often Venrock (4 rounds together), Mérieux Développement (3 rounds together) and Nano Dimension (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it